These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 21269587

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK, Houghton SG, Milliner DS, Lieske JC, Sarr MG.
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [Abstract] [Full Text] [Related]

  • 4. Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure.
    Nasr SH, D'Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, Markowitz GS.
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1676-83. PubMed ID: 18701613
    [Abstract] [Full Text] [Related]

  • 5. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
    Agrawal V, Liu XJ, Campfield T, Romanelli J, Enrique Silva J, Braden GL.
    Surg Obes Relat Dis; 2014 Nov; 10(1):88-94. PubMed ID: 23953730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG, Pedro RN, Makhlouf A, Kriedberg C, Stessman M, Hinck B, Ikramuddin S, Kellogg T, Slusarek B, Monga M.
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. AA amyloidosis due to chronic oxalate arthritis and vasculitis in a patient with secondary oxalosis after jejunoileal bypass surgery.
    Cornelis T, Bammens B, Lerut E, Cosyn L, Goovaerts G, Westhovens R, Vanrenterghem Y.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3362-4. PubMed ID: 18632590
    [Abstract] [Full Text] [Related]

  • 17. Oxalate nephropathy due to 'juicing': case report and review.
    Getting JE, Gregoire JR, Phul A, Kasten MJ.
    Am J Med; 2013 Sep; 126(9):768-72. PubMed ID: 23830537
    [Abstract] [Full Text] [Related]

  • 18. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R, Lieske JC, Collazo-Clavell ML, Sarr MG, Olson ER, Vrtiska TJ, Bergstralh EJ, Li X.
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [Abstract] [Full Text] [Related]

  • 19. Acute changes in renal function after laparoscopic gastric surgery for morbid obesity.
    Sharma SK, McCauley J, Cottam D, Mattar SG, Holover S, Dallal R, Lord J, Danner O, Ramanathan R, Eid G, Schauer P.
    Surg Obes Relat Dis; 2006 May; 2(3):389-92. PubMed ID: 16925359
    [Abstract] [Full Text] [Related]

  • 20. Laparoscopic Roux-en-Y gastric bypass for the treatment of morbid obesity: experience with 50 patients.
    Khalaileh A, Matot I, Schweiger C, Appelbaum L, Elazary R, Keidar A.
    Isr Med Assoc J; 2008 May; 10(5):350-3. PubMed ID: 18605357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.